Evidence map›Paper›PMID 34950397›Full record

ArticleThe Neurohospitalist2022

COVID-19 Induced Miller Fisher Syndrome Presenting With Autonomic Dysfunction: A Unique Case Report and Review of Literature.

Subhrajyoti Biswas, Ritwik Ghosh, Arpan Mandal, Alak Pandit, Dipayan Roy, Samya Sengupta, Kaustav De, Bikash Chandra Swaika, Julián Benito-León

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Neurohospitalist, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Immune-Mediated Neuropathies: Pathophysiology and Management.International journal of molecular sciences · 2023
    Review
  7. Ocular adverse effects of COVID-19 vaccines: A systematic review.Journal of family medicine and primary care · 2022
    Review
  8. Article
  9. Miller Fisher syndrome associated with COVID 19.Journal of family medicine and primary care · 2022
    Article
  10. Article
  11. Review
  12. Miller Fisher syndrome following Pfizer COVID-19 vaccine.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Subhrajyoti BiswasDepartment of General Medicine, Burdwan Medical College & Hospital, Burdwan, West Bengal, India.
Ritwik GhoshDepartment of General Medicine, Burdwan Medical College & Hospital, Burdwan, West Bengal, India.ORCID https://orcid.org/0000-0002-8192-0807
Arpan MandalDepartment of General Medicine, Burdwan Medical College & Hospital, Burdwan, West Bengal, India.
Alak PanditDepartment of Neuromedicine, Bangur Institute of Neurosciences, Kolkata, India.
Dipayan RoyDepartment of Biochemistry, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India.
Samya SenguptaDepartment of General Medicine, Apollo Gleneagles Hospitals, Kolkata, West Bengal, India.
Kaustav DeDepartment of General Medicine, Burdwan Medical College & Hospital, Burdwan, West Bengal, India.
Bikash Chandra SwaikaDepartment of General Medicine, Burdwan Medical College & Hospital, Burdwan, West Bengal, India.
Julián Benito-LeónDepartment of Neurology, University Hospital "12 de Octubre", Madrid, Spain.ORCID https://orcid.org/0000-0002-1769-4809
Burdwan Medical College & Hospital · INAll India Institute of Medical Sciences Jodhpur · INApollo Gleneagles Hospitals · INBangur Institute of Neurosciences · INUniversidad Complutense de Madrid · ES

Funding

ENVIRONMENTAL EPIDEMIOLOGY OF ESSENTIAL TREMORR01NS039422 · NINDS · YALE UNIVERSITY · PI LOUIS, ELAN D · 2000 to 2013
$7.7M
NINDS NIH HHS R01 NS039422
6 · The paper itself

Abstract

A plethora of neurological manifestations are associated with the 2019 coronavirus infectious disease (COVID-19). We hereby report the first case of a patient infected with SARS-CoV-2 who acutely presented with autonomic dysfunction preceding the onset of complete clinical picture of Miller Fisher syndrome. She was finally diagnosed to be a case of anti-ganglioside antibody positive post-COVID-19 Miller Fisher syndrome with dysautonomia and treated with intravenous immunoglobulin with an excellent response. We also discuss the plausible pathogenic mechanisms of COVID-19 induced Miller Fisher syndrome and furnish a review of the post-COVID-19 Miller Fisher syndrome cases reported.

Indexed as

Autonomic dysfunctionCOVID-19Miller Fisher syndrome (MFS)SARS-CoV-2

Identifiers

PMID34950397
PMCPMC8689536
OpenAlexW3161119139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.